TickerFacts.

Vitaspring Biomedical Co. Ltd. (VSBC): Operating Cash Flow

Annual figures by period end, from SEC filings.

-$2.7K
Year ended 2026-01-31
$10.6K
Trailing 12 months to 2026-07-31
$4012017-01-31: -$4.0K2018-01-31: $4012019-01-31: -$34.2K2020-01-31: -$1052021-01-31: -$42.1K2022-01-31: -$269.6K2023-01-31: -$77.6K2024-01-31: -$34.9K2025-01-31: -$14.7K2026-01-31: -$2.7K-$2.7K
2017-01-31 Operating Cash Flow (USD) 2026-01-31
Period endedOperating Cash FlowChange YoYSource filing
2026-01-31-$2.7Kn/m2026-06-17, From 2025-02-01
2025-01-31-$14.7Kn/m2026-06-17, From 2024-02-01
2024-01-31-$34.9Kn/m2026-06-08, From 2023-02-01
2023-01-31-$77.6Kn/m2026-03-12, From 2022-02-01
2022-01-31-$269.6Kn/m2025-12-01, From 2021-02-01
2021-01-31-$42.1Kn/m2022-05-03, From 2020-02-01
2020-01-31-$105n/m2021-04-14, From 2019-02-04
2019-01-31-$34.2Kn/a2020-06-09, From 2018-02-08
2018-01-31$401n/m2019-04-26, From 2017-02-01
2017-01-31-$4.0Kn/a2018-05-16, From 2016-02-01

Operating Cash Flow at similar companies

Companies with the same SEC industry code (Services-Commercial Physical & Biological Research), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedOperating Cash FlowChange YoY
Vitaspring Biomedical Co. Ltd. (VSBC)2026-01-31-$2.7Kn/m
NRC Health (NRC)2025-12-31$26.45M-23.6%
Incyte Corp (INCY)2025-12-31$1.41B+321.5%
Icon PLC (ICLR)2025-12-31$1.04B-19.5%
Charles River Laboratories International, Inc. (CRL)2025-12-27$737.65M+0.4%
MaxCyte, Inc. (MXCT)2025-12-31-$34.41Mn/m
Cannabis Bioscience International Holdings, Inc. (CBIH)2025-05-31-$329.6Kn/m
Iqvia Holdings Inc. (IQV)2025-12-31$2.65B-2.3%
iSpecimen Inc. (ISPC)2025-12-31-$4.24Mn/m

Compare VSBC, NRC, INCY, ICLR side by side · Screen every company in Services-Commercial Physical & Biological Research ↗